Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$4.27B |
| 2 |
Apple
AAPL
|
+$2.66B |
| 3 |
Philip Morris
PM
|
+$1.71B |
| 4 |
Oracle
ORCL
|
+$1.63B |
| 5 |
NVIDIA
NVDA
|
+$1.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.92B |
| 2 |
UnitedHealth
UNH
|
+$2.3B |
| 3 |
Boeing
BA
|
+$2.28B |
| 4 |
Shopify
SHOP
|
+$1.22B |
| 5 |
Las Vegas Sands
LVS
|
+$1.09B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.32% |
| 2 | Healthcare | 13.6% |
| 3 | Consumer Discretionary | 12.18% |
| 4 | Financials | 10.03% |
| 5 | Industrials | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Addus HomeCare
ADUS
$2.2B
| $158M | 0.03% |
1,469,752
+268,192
| +22% | +$30.8M |
|
252
Walmart Inc
WMT
$917B
| $156M | 0.03% |
1,404,306
-485,566
| -26% | -$52.1M |
|
253
Copart
CPRT
$26.9B
| $156M | 0.03% |
3,972,849
-5,374,719
| -57% | -$223M |
|
254
Home BancShares
HOMB
$6.26B
| $155M | 0.03% |
5,588,267
+238,548
| +4% | +$6.62M |
|
|
CHYM
255
Chime Financial
CHYM
$12.1B
| $154M | 0.03% |
6,102,983
-775,074
| -11% | -$16.5M |
|
256
Goldman Sachs
GS
$305B
| $153M | 0.03% |
174,257
-51,867
| -23% | -$42.3M |
|
257
CSX Corp
CSX
$93.7B
| $153M | 0.03% |
4,218,274
+3,802
| +0.1% | +$136K |
|
258
Yum! Brands
YUM
$41.4B
| $151M | 0.03% |
1,001,138
+521
| +0.1% | +$77.2K |
|
259
BioMarin Pharmaceuticals
BMRN
$13.4B
| $151M | 0.03% |
2,547,287
+9,691
| +0.4% | +$528K |
|
260
Kimberly-Clark
KMB
$36.5B
| $151M | 0.03% |
1,493,928
+929
| +0.1% | +$102K |
|
261
MakeMyTrip
MMYT
$5.65B
| $150M | 0.03% |
+1,827,439
| New | +$150M |
|
262
Oshkosh
OSK
$9.36B
| $150M | 0.03% |
1,193,156
+704,022
| +144% | +$90.6M |
|
263
Bio-Rad Laboratories Class A
BIO
$9.62B
| $150M | 0.03% |
494,472
+76,117
| +18% | +$23.8M |
|
264
DT Midstream
DTM
$13.8B
| $150M | 0.03% |
1,249,418
+317
| +0% | +$36.4K |
|
265
Champion Homes
SKY
$5.15B
| $149M | 0.03% |
1,757,463
-4,915
| -0.3% | -$387K |
|
266
SouthState Bank Corp
SSB
$10.8B
| $148M | 0.03% |
1,576,502
-94,999
| -6% | -$8.8M |
|
267
BridgeBio Pharma
BBIO
$16B
| $148M | 0.03% |
1,934,698
+1,572
| +0.1% | +$103K |
|
268
CBIZ
CBZ
$2.96B
| $147M | 0.03% |
2,914,541
-6,785
| -0.2% | -$357K |
|
269
Patria Investments
PAX
$1.83B
| $146M | 0.03% |
9,182,088
-28,755
| -0.3% | -$430K |
|
270
Exelon
EXC
$46.9B
| $143M | 0.03% |
3,288,892
+20,553
| +0.6% | +$938K |
|
271
Restaurant Brands International
QSR
$26.7B
| $139M | 0.03% |
2,040,125
+1,380
| +0.1% | +$95.1K |
|
272
Rogers Corp
ROG
$2.49B
| $139M | 0.03% |
1,519,040
+297,380
| +24% | +$25.5M |
|
273
Molina Healthcare
MOH
$10.8B
| $138M | 0.03% |
795,909
+3,123
| +0.4% | +$513K |
|
274
ICF International
ICFI
$1.57B
| $137M | 0.03% |
1,604,524
-2,937
| -0.2% | -$249K |
|
275
Woodward
WWD
$21.3B
| $134M | 0.02% |
444,785
-1,444,088
| -76% | -$397M |
|
Similar funds
Capital Research Global Investors's Q4 2025 Portfolio in Review
As of Q4 2025, Capital Research Global Investors held 465 positions worth $542B, up 1.6% from $533B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Capital Research Global Investors's Q4 2025 filing shows 31 new, 212 increased, 169 reduced and 31 closed positions. Its largest new stake was Medline Inc: 14,784,203 shares worth $621M. The largest sale was Meta Platforms (Facebook), an estimated $3.92B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q4 2025 buy was Medline Inc: 14,784,203 shares worth $621M.
- Capital Research Global Investors added most to Applied Materials in Q4 2025, an estimated $4.27B increase.
- Capital Research Global Investors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $3.92B.
- Capital Research Global Investors fully exited nVent Electric in Q4 2025, selling an estimated $379M.
- Capital Research Global Investors's ten largest holdings make up 39% of its $542B portfolio in Q4 2025.
- Capital Research Global Investors opened 31 new positions and closed 31 in Q4 2025.
- Capital Research Global Investors's portfolio value rose 1.6% quarter-over-quarter to $542B.
Based on Capital Research Global Investors's 13F filing for Q4 2025, filed 11 Feb 2026.